Researchers at Ohio State University have identified patterns of RNA molecules that predict response to therapy and overall survival among older acute myeloid leukemia patients.
Read More
Ultra-sensitive detection of minimal residual disease now available to more people with blood cancers.
Read More
The test has been shown to offer sensitivity for the detection of residual cancer cells in marrow or blood.
Read MoreAbbott has received 510(k) clearance from the FDA for a new in vitro diagnostic test to aid in determining the prognosis of patients with acute myeloid leukemia
Read MoreSunesis Pharmaceuticals’ vosaroxin would be used in combination with cytarabine to treat acute myeloid leukemia.
Read More